Insigma Technology (SHA:600797) said its joint-stock company completed listing on the Hong Kong Stock Exchange, according to a Shanghai Stock Exchange disclosure on Friday.
Hangzhou Jiuyuan Gene Engineering (HKG:2566) was listed on Nov. 28, offering 45.4 million shares for HK$12.42 apiece.
After the completion of the listing, the Chinese information technology services provider, through subsidiary Netnew Ventures, holds 24.5 million shares or 9.99% of Jiuyuan Gene Engineering. Netnew Ventures' lock-up period for Jiuyuan Gene shares is 12 months after the listing.
Insigma Technology's shares rose more than 2%, while Jiuyuan Gene Engineering's shares rose more than 4% in recent trade.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。